Trial NCT04913675

View at ClinicalTrials.gov 
Org. Study IDs: VIR-7831-5008

Last trial update was posted on 2024-03-07

MeSH Interventions

Sotrovimab

MeSH Conditions

COVID-19

Other Conditions

Covid19

Stopping Reasons

The safety sub-study was discontinued early in the context of evolving variants with increased fold changes in the in vitro half maximal inhibitory concentration (IC50) and uncertainty in the clinical relevance of these changes

Limitations And Caveats

The pre-specified daily imputation resulted in overly high inflation in the estimated progression rates for missing data. To reduce this bias and to account for progression history, weekly imputation was used for final conclusions.

Result Publications

N/A

Annotations

Category Annotations
No annotators decided on categories yet

Intervention Annotations
# Outdated Intervention Condition
Name Route DrugBank ID